Newsletter Subject

Urgent

From

ragingbull.com

Email Address

support@ragingbull.com

Sent On

Tue, Oct 6, 2020 01:23 PM

Email Preheader Text

Kyle Dennis just sent out this important message about the catalysts he sees in the biotech sector,

[RagingBull Elite]( Kyle Dennis just sent out this important message about the catalysts he sees in the biotech sector, and how he intends to profit from them. He’s identified three stocks, each with 4X - 5X return potential. Make sure you read Kyle’s message below in detail, so you know what’s at stake. You don’t want to miss out on this opportunity. Trader, At the end of January, I sent this image to my subscribers: Little did I know that the Covid-19 pandemic would put a strangle on the economy and almost wipe it out a month later. And while this unfortunate event has caused a lot of hardship to people. I tried to remain positive. Instead of shorting stocks when the market was crashing, I was buying biotech stocks working on cures for Covid-19, and other stay-at-home stocks. I made millions doing it…* Right now, you are probably hearing about all the uncertainty in the market. - The upcoming election, - The rapid rise of COVID-19 cases - What the next stimulus will look like - The President’s recovery - The next earnings cycle If I listened to the talking heads, there is no way I would have reached these heights in 2020. I’m telling you… Right now, we could be looking at some of the most explosive opportunities in the biotech space. In fact, I have three plays that I’m looking to make a move on very shortly. For each $10K I put in, I’m looking to bring back $40-$50K on each of these. I know that might sound crazy… But I’ve already… ...conducted all the hard-nosed research ...scanned through the charts and hunted down the most favorable setups ...lasered in on the cheapest stocks which offered the best risk to reward The three stocks I’m targeting are involved in vaccination, therapeutics, and diagnostics. How do you get your hands on them? The first-alert, which could go out at any moment, will be delivered to anyone who is subscribed to [Trade With Kyle](. That is my premier catalyst trading service. And where I make my biotech catalyst trades.* As a subscriber you receive: - My Video Watchlist. Once I week I record myself on camera flipping through charts and dissecting the markets, outlining what plays I’m eyeing and the opportunity I see in them. - Live Portfolio Stream. How does an eight-figure trader manage their portfolio in real-time? I’ll give you streaming access when you join. - Real-Time Trade Alerts: Stocks, options, it doesn’t matter, I trade them all. My alerts come with complete trading plans (entry, exit, profit target, and stop loss) - Trading Academy: Dozens of hours of recorded training sessions. Learn my strategies at your own pace. And discover how to beat the market trading biotech catalysts. Now here’s the best part. I usually only sell [Trade With Kyle]( on an annual and unlimited basis. However, the way I’m feeling about these upcoming plays, and biotechs over the next few months, I want to do something special. That’s why I’m slashing the price of Trade With Kyle (normally $1499 annual) to just $299 (quarterly). That’s right… less than $100 per month locks you into my premiere catalyst trading and education service. [It doesn’t get any better than this](. But you must hurry. [This will be on a first-come, first-served basis.]( [Don’t miss it.]( Kyle Dennis *Results presented are not typical and may vary from person to person. Please see our disclaimer here: [ragingbull.com/disclaimer]( RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from support@ragingbull.com]( [Unsubscribe from all RagingBull emails]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website,application or other service ("Services"), please review our full disclaimer located at [(disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication.

Marketing emails from ragingbull.com

View More
Sent On

04/12/2024

Sent On

03/12/2024

Sent On

03/12/2024

Sent On

29/11/2024

Sent On

27/11/2024

Sent On

26/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.